GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Rasheeda Bush and her son, Brian Bush, have together lost over 200 pounds using diabetes and weight loss medications.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Tori Spelling made headlines earlier this year when she revealed she used a pharmaceutical drug to lose the weight she’d ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...